Scholars Central

Research articlePublished 27 Apr 2021

Clinical Characteristics of Bacteremia Caused by Extended-Spectrum ?- Lactamase-Producing Escherichia coli and Outcome in Relation to Empiric Therapy

Authors: Kentaro Kikuchi, Chiyoko Motegi, Sayuri Osaki, Kotaro Matsumoto, Hiromichi Tsunashima, Tomohiro Kikuyama, Hikari Fujioka, Juri Kubota, Kozue Nagumo, Sho Ohyatsu, Tomoyuki Nariyama, Minoru Yoshida

Clinical Microbiology: Open Access

Volume 10 · Issue 4 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We investigated the clinical characteristics of 30 inpatients with ESBL-producing Escherichia col ibacteremia (ESBL group) and 85 inpatients with non-ESBL-producing E. coli bacteremia (non-ESBL group) and evaluated the relationship between empiric therapy and prognosis. In the ESBL group, urinary tract infection was most frequently. Most patients were hospitalized, had a history of admission to geriatric health care facilities, or intravenous antimicrobial drug injection. The rate of patients to whom susceptible antimicrobial drugs were administered as empiric therapy was significantly lower in the ESBL group than non-ESBL group (50 vs. 100%, p=0.0001). The total antimicrobial drug administration period in the ESBL group with ineffective empiric therapy was significantly longer than non-ESBL group (14.1 ± 3.1 vs. 9.9 ± 3.7 days, p=0.03). The mortality rate in the ESBL group with ineffective empiric therapy was significantly higher than ESBL group with effective empiric therapy and non-ESBL group (26.7% vs. 0%, 8.2%, p<0.05). In conclusion, when treating patients with bacteremia of E. coli due to urinary tract infection, with a history of admission to geriatric health care facilities, admission to hospitals, or intravenous antimicrobial drug injection, empiric therapy under the assumption of ESBL-producing E. coli may be shortened the total antimicrobial drug administration period and reducing mortality.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Microbiology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Microbiology: Open Access
  • SubjectMicrobiology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Kentaro Kikuchi”
  • BylineArticles whose byline prints “Chiyoko Motegi”
  • BylineArticles whose byline prints “Sayuri Osaki”
  • BylineArticles whose byline prints “Kotaro Matsumoto”
  • BylineArticles whose byline prints “Hiromichi Tsunashima”
  • BylineArticles whose byline prints “Tomohiro Kikuyama”
  • BylineArticles whose byline prints “Hikari Fujioka”
  • BylineArticles whose byline prints “Juri Kubota”